← All companies

DRMA

Dermata Therapeutics, Inc.

DRMA Nasdaq Pharmaceutical Preparations EDGAR ↗

$1.08

-0.10 -8.90%

Key statistics

from XBRL data in SEC filings

Market cap

$4.32M

Revenue (TTM)

—

Net income (TTM)

-$7.10M

EPS (TTM)

$-4.17

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$6.95M

Total assets

$7.47M

Gross margin

—

52-week range

$0.95 – $7.14

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change; Shareholder vote results May 27, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Results of operations (earnings release) Mar 26, 2026 8-K Director or officer change Feb 25, 2026 8-K Changed accountants Feb 3, 2026 8-K Other events Jan 27, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events Dec 29, 2025 8-K Terminated a material agreement Nov 18, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 14, 2025 8-K Other events Nov 7, 2025 8-K Other events Sep 17, 2025 8-K Other events Sep 10, 2025 8-K Other events Aug 25, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 13, 2025 8-K Modified rights of security holders; Amended charter or bylaws Jul 30, 2025 8-K Shareholder vote results Jul 16, 2025 8-K Delisting notice or listing-rule failure Jul 7, 2025 8-K Changed accountants Jun 5, 2025 8-K Regulation FD disclosure; Other events May 21, 2025 8-K Delisting notice or listing-rule failure May 16, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 14, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Regulation FD disclosure; Other events Apr 15, 2025 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders Mar 28, 2025 8-K Regulation FD disclosure; Other events Mar 27, 2025 8-K Delisting notice or listing-rule failure Mar 25, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 17, 2025 10-K Fiscal year ended 2024-12-31 Mar 17, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jan 23, 2025 8-K Entered a material agreement; Regulation FD disclosure Jan 21, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Sep 17, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 7, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Other events Aug 2, 2024